Global Drugs for Schistosomiasis Market Insights and Forecast to 2028

Report ID: 1201209 | Published Date: Oct 2024 | No. of Page: 97 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Drugs for Schistosomiasis Product Introduction
    1.2 Market by Type
        1.2.1 Global Drugs for Schistosomiasis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Praziquantel
        1.2.3 Oxamniquine
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Drugs for Schistosomiasis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 S. haematobium
        1.3.3 S. mansoni
        1.3.4 S. japonicum
        1.3.5 S. mekongi
        1.3.6 S. intercalatum
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Drugs for Schistosomiasis Sales Estimates and Forecasts 2017-2028
    2.2 Global Drugs for Schistosomiasis Revenue Estimates and Forecasts 2017-2028
    2.3 Global Drugs for Schistosomiasis Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Drugs for Schistosomiasis Sales by Region
        2.4.1 Global Drugs for Schistosomiasis Sales by Region (2017-2022)
        2.4.2 Global Sales Drugs for Schistosomiasis by Region (2023-2028)
    2.5 Global Drugs for Schistosomiasis Revenue by Region
        2.5.1 Global Drugs for Schistosomiasis Revenue by Region (2017-2022)
        2.5.2 Global Drugs for Schistosomiasis Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Drugs for Schistosomiasis Sales by Manufacturers
        3.1.1 Global Top Drugs for Schistosomiasis Manufacturers by Sales (2017-2022)
        3.1.2 Global Drugs for Schistosomiasis Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drugs for Schistosomiasis in 2021
    3.2 Global Drugs for Schistosomiasis Revenue by Manufacturers
        3.2.1 Global Drugs for Schistosomiasis Revenue by Manufacturers (2017-2022)
        3.2.2 Global Drugs for Schistosomiasis Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Drugs for Schistosomiasis Revenue in 2021
    3.3 Global Drugs for Schistosomiasis Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Drugs for Schistosomiasis Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Drugs for Schistosomiasis Sales by Type
        4.1.1 Global Drugs for Schistosomiasis Historical Sales by Type (2017-2022)
        4.1.2 Global Drugs for Schistosomiasis Forecasted Sales by Type (2023-2028)
        4.1.3 Global Drugs for Schistosomiasis Sales Market Share by Type (2017-2028)
    4.2 Global Drugs for Schistosomiasis Revenue by Type
        4.2.1 Global Drugs for Schistosomiasis Historical Revenue by Type (2017-2022)
        4.2.2 Global Drugs for Schistosomiasis Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Drugs for Schistosomiasis Revenue Market Share by Type (2017-2028)
    4.3 Global Drugs for Schistosomiasis Price by Type
        4.3.1 Global Drugs for Schistosomiasis Price by Type (2017-2022)
        4.3.2 Global Drugs for Schistosomiasis Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Drugs for Schistosomiasis Sales by Application
        5.1.1 Global Drugs for Schistosomiasis Historical Sales by Application (2017-2022)
        5.1.2 Global Drugs for Schistosomiasis Forecasted Sales by Application (2023-2028)
        5.1.3 Global Drugs for Schistosomiasis Sales Market Share by Application (2017-2028)
    5.2 Global Drugs for Schistosomiasis Revenue by Application
        5.2.1 Global Drugs for Schistosomiasis Historical Revenue by Application (2017-2022)
        5.2.2 Global Drugs for Schistosomiasis Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Drugs for Schistosomiasis Revenue Market Share by Application (2017-2028)
    5.3 Global Drugs for Schistosomiasis Price by Application
        5.3.1 Global Drugs for Schistosomiasis Price by Application (2017-2022)
        5.3.2 Global Drugs for Schistosomiasis Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Drugs for Schistosomiasis Market Size by Type
        6.1.1 North America Drugs for Schistosomiasis Sales by Type (2017-2028)
        6.1.2 North America Drugs for Schistosomiasis Revenue by Type (2017-2028)
    6.2 North America Drugs for Schistosomiasis Market Size by Application
        6.2.1 North America Drugs for Schistosomiasis Sales by Application (2017-2028)
        6.2.2 North America Drugs for Schistosomiasis Revenue by Application (2017-2028)
    6.3 North America Drugs for Schistosomiasis Market Size by Country
        6.3.1 North America Drugs for Schistosomiasis Sales by Country (2017-2028)
        6.3.2 North America Drugs for Schistosomiasis Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Drugs for Schistosomiasis Market Size by Type
        7.1.1 Europe Drugs for Schistosomiasis Sales by Type (2017-2028)
        7.1.2 Europe Drugs for Schistosomiasis Revenue by Type (2017-2028)
    7.2 Europe Drugs for Schistosomiasis Market Size by Application
        7.2.1 Europe Drugs for Schistosomiasis Sales by Application (2017-2028)
        7.2.2 Europe Drugs for Schistosomiasis Revenue by Application (2017-2028)
    7.3 Europe Drugs for Schistosomiasis Market Size by Country
        7.3.1 Europe Drugs for Schistosomiasis Sales by Country (2017-2028)
        7.3.2 Europe Drugs for Schistosomiasis Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Drugs for Schistosomiasis Market Size by Type
        8.1.1 Asia Pacific Drugs for Schistosomiasis Sales by Type (2017-2028)
        8.1.2 Asia Pacific Drugs for Schistosomiasis Revenue by Type (2017-2028)
    8.2 Asia Pacific Drugs for Schistosomiasis Market Size by Application
        8.2.1 Asia Pacific Drugs for Schistosomiasis Sales by Application (2017-2028)
        8.2.2 Asia Pacific Drugs for Schistosomiasis Revenue by Application (2017-2028)
    8.3 Asia Pacific Drugs for Schistosomiasis Market Size by Region
        8.3.1 Asia Pacific Drugs for Schistosomiasis Sales by Region (2017-2028)
        8.3.2 Asia Pacific Drugs for Schistosomiasis Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Drugs for Schistosomiasis Market Size by Type
        9.1.1 Latin America Drugs for Schistosomiasis Sales by Type (2017-2028)
        9.1.2 Latin America Drugs for Schistosomiasis Revenue by Type (2017-2028)
    9.2 Latin America Drugs for Schistosomiasis Market Size by Application
        9.2.1 Latin America Drugs for Schistosomiasis Sales by Application (2017-2028)
        9.2.2 Latin America Drugs for Schistosomiasis Revenue by Application (2017-2028)
    9.3 Latin America Drugs for Schistosomiasis Market Size by Country
        9.3.1 Latin America Drugs for Schistosomiasis Sales by Country (2017-2028)
        9.3.2 Latin America Drugs for Schistosomiasis Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Drugs for Schistosomiasis Market Size by Type
        10.1.1 Middle East and Africa Drugs for Schistosomiasis Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Drugs for Schistosomiasis Revenue by Type (2017-2028)
    10.2 Middle East and Africa Drugs for Schistosomiasis Market Size by Application
        10.2.1 Middle East and Africa Drugs for Schistosomiasis Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Drugs for Schistosomiasis Revenue by Application (2017-2028)
    10.3 Middle East and Africa Drugs for Schistosomiasis Market Size by Country
        10.3.1 Middle East and Africa Drugs for Schistosomiasis Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Shin Poong
        11.1.1 Shin Poong Corporation Information
        11.1.2 Shin Poong Overview
        11.1.3 Shin Poong Drugs for Schistosomiasis Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Shin Poong Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Shin Poong Recent Developments
    11.2 Merck
        11.2.1 Merck Corporation Information
        11.2.2 Merck Overview
        11.2.3 Merck Drugs for Schistosomiasis Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Merck Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Merck Recent Developments
    11.3 Bayer
        11.3.1 Bayer Corporation Information
        11.3.2 Bayer Overview
        11.3.3 Bayer Drugs for Schistosomiasis Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Bayer Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Bayer Recent Developments
    11.4 EIPICO
        11.4.1 EIPICO Corporation Information
        11.4.2 EIPICO Overview
        11.4.3 EIPICO Drugs for Schistosomiasis Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 EIPICO Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 EIPICO Recent Developments
    11.5 Chandra Bhagat Pharma
        11.5.1 Chandra Bhagat Pharma Corporation Information
        11.5.2 Chandra Bhagat Pharma Overview
        11.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Chandra Bhagat Pharma Recent Developments
    11.6 Taj Pharmaceuticals
        11.6.1 Taj Pharmaceuticals Corporation Information
        11.6.2 Taj Pharmaceuticals Overview
        11.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Taj Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Drugs for Schistosomiasis Industry Chain Analysis
    12.2 Drugs for Schistosomiasis Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Drugs for Schistosomiasis Production Mode & Process
    12.4 Drugs for Schistosomiasis Sales and Marketing
        12.4.1 Drugs for Schistosomiasis Sales Channels
        12.4.2 Drugs for Schistosomiasis Distributors
    12.5 Drugs for Schistosomiasis Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Drugs for Schistosomiasis Industry Trends
    13.2 Drugs for Schistosomiasis Market Drivers
    13.3 Drugs for Schistosomiasis Market Challenges
    13.4 Drugs for Schistosomiasis Market Restraints
14 Key Findings in The Global Drugs for Schistosomiasis Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Drugs for Schistosomiasis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Praziquantel
    Table 3. Major Manufacturers of Oxamniquine
    Table 4. Major Manufacturers of Other
    Table 5. Global Drugs for Schistosomiasis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Drugs for Schistosomiasis Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Drugs for Schistosomiasis Sales by Region (2017-2022) & (M Units)
    Table 8. Global Drugs for Schistosomiasis Sales Market Share by Region (2017-2022)
    Table 9. Global Drugs for Schistosomiasis Sales by Region (2023-2028) & (M Units)
    Table 10. Global Drugs for Schistosomiasis Sales Market Share by Region (2023-2028)
    Table 11. Global Drugs for Schistosomiasis Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Drugs for Schistosomiasis Revenue Market Share by Region (2017-2022)
    Table 13. Global Drugs for Schistosomiasis Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Drugs for Schistosomiasis Revenue Market Share by Region (2023-2028)
    Table 15. Global Drugs for Schistosomiasis Sales by Manufacturers (2017-2022) & (M Units)
    Table 16. Global Drugs for Schistosomiasis Sales Share by Manufacturers (2017-2022)
    Table 17. Global Drugs for Schistosomiasis Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Drugs for Schistosomiasis Revenue Share by Manufacturers (2017-2022)
    Table 19. Drugs for Schistosomiasis Price by Manufacturers (2017-2022) &(USD/K Units)
    Table 20. Global Drugs for Schistosomiasis Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Drugs for Schistosomiasis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Schistosomiasis as of 2021)
    Table 22. Drugs for Schistosomiasis Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Drugs for Schistosomiasis Product Offered
    Table 24. Date of Manufacturers Enter into Drugs for Schistosomiasis Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
    Table 27. Global Drugs for Schistosomiasis Sales by Type (2023-2028) & (M Units)
    Table 28. Global Drugs for Schistosomiasis Sales Share by Type (2017-2022)
    Table 29. Global Drugs for Schistosomiasis Sales Share by Type (2023-2028)
    Table 30. Global Drugs for Schistosomiasis Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Drugs for Schistosomiasis Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Drugs for Schistosomiasis Revenue Share by Type (2017-2022)
    Table 33. Global Drugs for Schistosomiasis Revenue Share by Type (2023-2028)
    Table 34. Drugs for Schistosomiasis Price by Type (2017-2022) & (USD/K Units)
    Table 35. Global Drugs for Schistosomiasis Price Forecast by Type (2023-2028) & (USD/K Units)
    Table 36. Global Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
    Table 37. Global Drugs for Schistosomiasis Sales by Application (2023-2028) & (M Units)
    Table 38. Global Drugs for Schistosomiasis Sales Share by Application (2017-2022)
    Table 39. Global Drugs for Schistosomiasis Sales Share by Application (2023-2028)
    Table 40. Global Drugs for Schistosomiasis Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Drugs for Schistosomiasis Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Drugs for Schistosomiasis Revenue Share by Application (2017-2022)
    Table 43. Global Drugs for Schistosomiasis Revenue Share by Application (2023-2028)
    Table 44. Drugs for Schistosomiasis Price by Application (2017-2022) & (USD/K Units)
    Table 45. Global Drugs for Schistosomiasis Price Forecast by Application (2023-2028) & (USD/K Units)
    Table 46. North America Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
    Table 47. North America Drugs for Schistosomiasis Sales by Type (2023-2028) & (M Units)
    Table 48. North America Drugs for Schistosomiasis Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Drugs for Schistosomiasis Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
    Table 51. North America Drugs for Schistosomiasis Sales by Application (2023-2028) & (M Units)
    Table 52. North America Drugs for Schistosomiasis Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Drugs for Schistosomiasis Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Drugs for Schistosomiasis Sales by Country (2017-2022) & (M Units)
    Table 55. North America Drugs for Schistosomiasis Sales by Country (2023-2028) & (M Units)
    Table 56. North America Drugs for Schistosomiasis Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Drugs for Schistosomiasis Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
    Table 59. Europe Drugs for Schistosomiasis Sales by Type (2023-2028) & (M Units)
    Table 60. Europe Drugs for Schistosomiasis Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Drugs for Schistosomiasis Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
    Table 63. Europe Drugs for Schistosomiasis Sales by Application (2023-2028) & (M Units)
    Table 64. Europe Drugs for Schistosomiasis Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Drugs for Schistosomiasis Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Drugs for Schistosomiasis Sales by Country (2017-2022) & (M Units)
    Table 67. Europe Drugs for Schistosomiasis Sales by Country (2023-2028) & (M Units)
    Table 68. Europe Drugs for Schistosomiasis Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Drugs for Schistosomiasis Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
    Table 71. Asia Pacific Drugs for Schistosomiasis Sales by Type (2023-2028) & (M Units)
    Table 72. Asia Pacific Drugs for Schistosomiasis Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Drugs for Schistosomiasis Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
    Table 75. Asia Pacific Drugs for Schistosomiasis Sales by Application (2023-2028) & (M Units)
    Table 76. Asia Pacific Drugs for Schistosomiasis Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Drugs for Schistosomiasis Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Drugs for Schistosomiasis Sales by Region (2017-2022) & (M Units)
    Table 79. Asia Pacific Drugs for Schistosomiasis Sales by Region (2023-2028) & (M Units)
    Table 80. Asia Pacific Drugs for Schistosomiasis Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Drugs for Schistosomiasis Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
    Table 83. Latin America Drugs for Schistosomiasis Sales by Type (2023-2028) & (M Units)
    Table 84. Latin America Drugs for Schistosomiasis Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Drugs for Schistosomiasis Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
    Table 87. Latin America Drugs for Schistosomiasis Sales by Application (2023-2028) & (M Units)
    Table 88. Latin America Drugs for Schistosomiasis Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Drugs for Schistosomiasis Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Drugs for Schistosomiasis Sales by Country (2017-2022) & (M Units)
    Table 91. Latin America Drugs for Schistosomiasis Sales by Country (2023-2028) & (M Units)
    Table 92. Latin America Drugs for Schistosomiasis Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Drugs for Schistosomiasis Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
    Table 95. Middle East and Africa Drugs for Schistosomiasis Sales by Type (2023-2028) & (M Units)
    Table 96. Middle East and Africa Drugs for Schistosomiasis Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Drugs for Schistosomiasis Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
    Table 99. Middle East and Africa Drugs for Schistosomiasis Sales by Application (2023-2028) & (M Units)
    Table 100. Middle East and Africa Drugs for Schistosomiasis Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Drugs for Schistosomiasis Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Drugs for Schistosomiasis Sales by Country (2017-2022) & (M Units)
    Table 103. Middle East and Africa Drugs for Schistosomiasis Sales by Country (2023-2028) & (M Units)
    Table 104. Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Shin Poong Corporation Information
    Table 107. Shin Poong Description and Major Businesses
    Table 108. Shin Poong Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 109. Shin Poong Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Shin Poong Recent Developments
    Table 111. Merck Corporation Information
    Table 112. Merck Description and Major Businesses
    Table 113. Merck Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 114. Merck Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Merck Recent Developments
    Table 116. Bayer Corporation Information
    Table 117. Bayer Description and Major Businesses
    Table 118. Bayer Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 119. Bayer Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Bayer Recent Developments
    Table 121. EIPICO Corporation Information
    Table 122. EIPICO Description and Major Businesses
    Table 123. EIPICO Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 124. EIPICO Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. EIPICO Recent Developments
    Table 126. Chandra Bhagat Pharma Corporation Information
    Table 127. Chandra Bhagat Pharma Description and Major Businesses
    Table 128. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 129. Chandra Bhagat Pharma Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Chandra Bhagat Pharma Recent Developments
    Table 131. Taj Pharmaceuticals Corporation Information
    Table 132. Taj Pharmaceuticals Description and Major Businesses
    Table 133. Taj Pharmaceuticals Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
    Table 134. Taj Pharmaceuticals Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Taj Pharmaceuticals Recent Developments
    Table 136. Key Raw Materials Lists
    Table 137. Raw Materials Key Suppliers Lists
    Table 138. Drugs for Schistosomiasis Distributors List
    Table 139. Drugs for Schistosomiasis Customers List
    Table 140. Drugs for Schistosomiasis Market Trends
    Table 141. Drugs for Schistosomiasis Market Drivers
    Table 142. Drugs for Schistosomiasis Market Challenges
    Table 143. Drugs for Schistosomiasis Market Restraints
    Table 144. Research Programs/Design for This Report
    Table 145. Key Data Information from Secondary Sources
    Table 146. Key Data Information from Primary Sources
List of Figures
    Figure 1. Drugs for Schistosomiasis Product Picture
    Figure 3. Global Drugs for Schistosomiasis Market Share by Type in 2021 & 2028
    Figure 3. Praziquantel Product Picture
    Figure 4. Oxamniquine Product Picture
    Figure 5. Other Product Picture
    Figure 6. Global Drugs for Schistosomiasis Market Share by Application in 2021 & 2028
    Figure 7. S. haematobium
    Figure 8. S. mansoni
    Figure 9. S. japonicum
    Figure 10. S. mekongi
    Figure 11. S. intercalatum
    Figure 12. Drugs for Schistosomiasis Report Years Considered
    Figure 13. Global Drugs for Schistosomiasis Sales 2017-2028 (M Units)
    Figure 14. Global Drugs for Schistosomiasis Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Drugs for Schistosomiasis Revenue 2017-2028 (US$ Million)
    Figure 16. Global Drugs for Schistosomiasis Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Drugs for Schistosomiasis Sales Market Share by Region (2017-2022)
    Figure 18. Global Drugs for Schistosomiasis Sales Market Share by Region (2023-2028)
    Figure 19. North America Drugs for Schistosomiasis Sales YoY (2017-2028) & (M Units)
    Figure 20. North America Drugs for Schistosomiasis Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Drugs for Schistosomiasis Sales YoY (2017-2028) & (M Units)
    Figure 22. Europe Drugs for Schistosomiasis Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Drugs for Schistosomiasis Sales YoY (2017-2028) & (M Units)
    Figure 24. Asia-Pacific Drugs for Schistosomiasis Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Drugs for Schistosomiasis Sales YoY (2017-2028) & (M Units)
    Figure 26. Latin America Drugs for Schistosomiasis Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Drugs for Schistosomiasis Sales YoY (2017-2028) & (M Units)
    Figure 28. Middle East & Africa Drugs for Schistosomiasis Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Drugs for Schistosomiasis Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Drugs for Schistosomiasis in the World: Market Share by Drugs for Schistosomiasis Revenue in 2021
    Figure 31. Global Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Drugs for Schistosomiasis Sales Market Share by Type (2017-2028)
    Figure 33. Global Drugs for Schistosomiasis Revenue Market Share by Type (2017-2028)
    Figure 34. Global Drugs for Schistosomiasis Sales Market Share by Application (2017-2028)
    Figure 35. Global Drugs for Schistosomiasis Revenue Market Share by Application (2017-2028)
    Figure 36. North America Drugs for Schistosomiasis Sales Market Share by Type (2017-2028)
    Figure 37. North America Drugs for Schistosomiasis Revenue Market Share by Type (2017-2028)
    Figure 38. North America Drugs for Schistosomiasis Sales Market Share by Application (2017-2028)
    Figure 39. North America Drugs for Schistosomiasis Revenue Market Share by Application (2017-2028)
    Figure 40. North America Drugs for Schistosomiasis Sales Share by Country (2017-2028)
    Figure 41. North America Drugs for Schistosomiasis Revenue Share by Country (2017-2028)
    Figure 42. U.S. Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Drugs for Schistosomiasis Sales Market Share by Type (2017-2028)
    Figure 45. Europe Drugs for Schistosomiasis Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Drugs for Schistosomiasis Sales Market Share by Application (2017-2028)
    Figure 47. Europe Drugs for Schistosomiasis Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Drugs for Schistosomiasis Sales Share by Country (2017-2028)
    Figure 49. Europe Drugs for Schistosomiasis Revenue Share by Country (2017-2028)
    Figure 50. Germany Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 51. France Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Drugs for Schistosomiasis Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Drugs for Schistosomiasis Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Drugs for Schistosomiasis Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Drugs for Schistosomiasis Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Drugs for Schistosomiasis Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Drugs for Schistosomiasis Revenue Share by Region (2017-2028)
    Figure 61. China Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 64. India Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Drugs for Schistosomiasis Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Drugs for Schistosomiasis Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Drugs for Schistosomiasis Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Drugs for Schistosomiasis Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Drugs for Schistosomiasis Sales Share by Country (2017-2028)
    Figure 76. Latin America Drugs for Schistosomiasis Revenue Share by Country (2017-2028)
    Figure 77. Mexico Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Drugs for Schistosomiasis Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Drugs for Schistosomiasis Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Drugs for Schistosomiasis Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Drugs for Schistosomiasis Revenue Share by Country (2017-2028)
    Figure 86. Turkey Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 88. U.A.E Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
    Figure 89. Drugs for Schistosomiasis Value Chain
    Figure 90. Drugs for Schistosomiasis Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
Frequently Asked Questions
Drugs for Schistosomiasis report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Drugs for Schistosomiasis report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Drugs for Schistosomiasis report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Hoist

Hoist market is segmented by Type and by Application. Players, stakeholders, and other participan ... Read More